Guidelines for preparation and submission of abstracts (APLD-2016):
1. Abstracts may only be submitted via internet on this website. Abstracts submitted by fax or email will not be accepted.
2. All abstracts must be submitted in English.
3. Abstracts that have been published before are NOT accepted. However, abstracts presented at local, regional or national meetings may be submitted.
4. Participants are invited to submit abstracts under any of the categories listed below.
5. Abstract title is limited to 25 words. Do not define or use abbreviations in the title.
6. Author or authors’ names should be written as follows; family name, initial(s) of first name(s) (e.g. Smith, JC). The name of the presenting author must be underlined. Affiliation details of all authors are included; Department; Institution / Hospital; City; State/Province (if relevant); Country
7. The abstract text must not exceed 300 words (excluding title and authors). The abstract must be typed in a font size of 11 pt and in Times New Roman and should be organized as follows:
Background & Aims
Methods
Results
Conclusion (avoid statements like “the findings will be discussed”.)
8. Use only standard abbreviations in the abstract text. Place special or unusual abbreviations in parentheses after the full word the first time it appears. Do not use footnotes or references in the abstracts.
9. Each abstract should not have more than one Figure and one Table. Table and Figure should be submitted in JPG format in the insert image module. Maximum size is 1024 x 768 pixels.
10. After having submitted your abstract, you will receive a confirmation by e-mail with your abstract reference number and personal address code and password. If you do not receive a confirmation by e-mail please contact apld2016@vnuexhibitionsap.com
11. If an abstract is accepted, one author must register, attend the conference and present it in person.
List of Abstract Categories
1. Basic Science of Hepatology
2. Acute Liver Failure / Acute on Chronic Liver Failure
3. Alcoholic Liver Disease
4. Non-alcoholic Fatty Liver Disease (NAFLD)
5. Autoimmune Hepatitis and Cholestatic Liver Disease
6. Metabolic and Genetic Disease
7. Pediatric Hepatology
8. Drug induced Liver Disease (DILI)
9. Hepatitis B
10. Hepatitis C
11. Other Viral Hepatitis
12. Non-Invasive Markers of Liver Fibrosis
13. Cirrhosis and Complications
14. Hepatocellular Carcinoma
15. Cholangiocarcinoma and Other Liver Neoplasm
16. Gallbladder and Biliary Tract Disease
17. ERCP and interventional Hepatology
18. Liver Transplantation/Surgery
19. Imaging Modalities
20. Case Report and Case Series
21. Miscellaneous